Gamma Investing LLC Biotechnology

Gamma Investing LLC

$1.01 Trillion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
DAWN Day One Biopharmaceuticals, Inc.	$1B	$947,000 0.0% of portfolio	68	Q3 2024 Added 61.9%
VNDA Vanda Pharmaceuticals Inc.	$277M	$929,000 0.0% of portfolio	198	Q3 2024 Reduced 16.1%
KMPH Kempharm, Inc	$170M	$923,000 0.0% of portfolio	133	Q3 2024 New
VYGR Voyager Therapeutics, Inc.	$207M	$866,000 0.0% of portfolio	148	Q3 2024 Reduced 21.28%
EYPT Eye Point Pharmaceuticals, Inc.	$305M	$847,000 0.0% of portfolio	106	Q3 2024 Added 202.86%
ETNB 89bio, Inc.	$371M	$814,000 0.0% of portfolio	110	Q3 2024 Added 816.67%
ABSI Absci Corp	$249M	$760,000 0.0% of portfolio	199	Q4 2023 New
ABUS Arbutus Biopharma Corp	$516M	$720,000 0.0% of portfolio	187	Q4 2023 New
FULC Fulcrum Therapeutics, Inc.	$156M	$707,000 0.0% of portfolio	198	Q3 2024 New
TCRX T Scan Therapeutics, Inc.	$78M	$707,000 0.0% of portfolio	142	Q3 2024 New
KALV Kal Vista Pharmaceuticals, Inc.	$220M	$683,000 0.0% of portfolio	59	Q3 2024 New
TRDA Entrada Therapeutics, Inc.	$566M	$639,000 0.0% of portfolio	40	Q1 2024 New
MGNX Macrogenics Inc	$202M	$625,000 0.0% of portfolio	190	Q3 2024 Reduced 84.54%
SAGE Sage Therapeutics, Inc.	$292M	$549,000 0.0% of portfolio	76	Q3 2024 Reduced 43.28%
ARVN Arvinas, Inc.	$1.21B	$542,000 0.0% of portfolio	22	Q3 2024 Reduced 58.49%
YMAB Y M Abs Therapeutics, Inc.	$461M	$526,000 0.0% of portfolio	40	Q3 2024 Added 700.0%
EDIT Editas Medicine, Inc.	$166M	$467,000 0.0% of portfolio	137	Q3 2024 Reduced 90.97%
RVNC Revance Therapeutics, Inc.	$212M	$462,000 0.0% of portfolio	89	Q3 2024 New
ORIC Oric Pharmaceuticals, Inc.	$346M	$441,000 0.0% of portfolio	43	Q3 2024 Reduced 45.57%
FDMT 4 D Molecular Therapeutics, Inc.	$272M	$432,000 0.0% of portfolio	40	Q3 2024 Reduced 2.44%
SANA Sana Biotechnology, Inc.	$481M	$366,000 0.0% of portfolio	88	Q3 2024 Reduced 12.87%
OCUL Ocular Therapeutix, Inc	$676M	$331,000 0.0% of portfolio	38	Q3 2024 New
ENTA Enanta Pharmaceuticals Inc	$188M	$300,000 0.0% of portfolio	29	Q3 2024 Reduced 32.56%
QURE Uni Qure N.V.	$266M	$296,000 0.0% of portfolio	60	Q3 2024 New
GLUE Monte Rosa Therapeutics, Inc.	$391M	$292,000 0.0% of portfolio	55	Q3 2024 Added 5.77%
LRMR Larimar Therapeutics, Inc.	$256M	$288,000 0.0% of portfolio	44	Q3 2024 New
IPSC Century Therapeutics, Inc.	$74.2M	$224,000 0.0% of portfolio	131	Q3 2024 Reduced 25.57%
AURA Aura Biosciences, Inc.	$256M	$223,000 0.0% of portfolio	25	Q3 2024 New
CADL Candel Therapeutics, Inc.	$116M	$201,000 0.0% of portfolio	29	Q3 2024 New
INZY Inozyme Pharma, Inc.	$110M	$141,000 0.0% of portfolio	27	Q3 2024 Added 12.5%
ALDX Aldeyra Therapeutics, Inc.	$278M	$135,000 0.0% of portfolio	25	Q3 2024 New
GBIO Generation Bio Co.	$79.7M	$124,000 0.0% of portfolio	50	Q3 2024 Reduced 36.71%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.